07.01.2025
In the past fiscal year, SCHOTT recorded a slight decline in revenue of 1%, with revenues of EUR 2.8 billion. Adjusted for currency effects, revenue increased by 3%. Business in the pharmaceutical, optics, and semiconductor industries contributed
更多
09.10.2024
In June 2023, Dr. Frank Heinricht, Chairman of the Management Board of SCHOTT AG, informed the Supervisory Board
更多
19.07.2024
SCHOTT Pharma introduces new 10ml ready-to-use (RTU) cartridges, specifically designed to store highly sensitive biologics used to treat cancer, metabolic disorders, cardiovascular conditions, genetic disorders, and immunological
更多
24.03.2024
SCHOTT Pharma, a pioneer in pharmaceutical drug containment solutions and delivery systems, will build the first U.S. facility to manufacture prefillable polymer syringes required to meet the need for deep-cold storage and transportation of mRNA
更多
09.01.2024
SCHOTT Pharma’s products serve the growing market for injectable
更多
13.10.2023
Federal Ministry of Economics promotes innovative technological
更多